| NCT ID | NCT06522022 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Emory University |
| Condition | Pregnancy Early |
| Study Type | INTERVENTIONAL |
| Enrollment | 804 participants |
| Start Date | 2025-02-20 |
| Primary Completion | 2029-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 804 participants in total. It began in 2025-02-20 with a primary completion date of 2029-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will compare the effectiveness of two active screening interventions in improving post-traumatic stress disorder (PTSD) symptoms, maternal perinatal care utilization, satisfaction utilization of mental healthcare services, and maternal health and birth-related outcomes for Black pregnant women.
Eligibility Criteria
Inclusion Criteria: * 18+ years old, * Ability to provide informed consent, * English-speaking, * Willingness to participate in the study, * Self-identification as Black or African American, * Pregnant and in the first trimester attending initial prenatal care visit, * Endorsement of at least one traumatic event in their lifetime. Exclusion Criteria: * Active suicidality
Contact & Investigator
Abigail Lott, PhD, ABPP
PRINCIPAL INVESTIGATOR
Emory University
Frequently Asked Questions
Who can join the NCT06522022 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pregnancy Early. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06522022 currently recruiting?
Yes, NCT06522022 is actively recruiting participants. Contact the research team at abigail.lott@emoryhealthcare.org for enrollment information.
Where is the NCT06522022 trial being conducted?
This trial is being conducted at Atlanta, United States, Kansas City, United States.
Who is sponsoring the NCT06522022 clinical trial?
NCT06522022 is sponsored by Emory University. The principal investigator is Abigail Lott, PhD, ABPP at Emory University. The trial plans to enroll 804 participants.